Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models.
about
Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargetingAntiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.Oncolytic Immunotherapy for Treatment of Cancer.Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells.Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas.Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity.Tumor Restrictions to Oncolytic Virus.
P2860
Q35717021-4645F792-7FF7-4D63-808A-F13215ABF273Q36086370-E759BA1A-8526-421A-BDC6-2835CD6F7774Q36506773-9E298E37-24F8-46C1-822D-C2BB21986F00Q38218674-E666036D-8C1F-4F95-AAC1-65FC9BD23ED5Q38701864-DB690886-ACC0-4F74-9AFE-0229D42045FFQ38848223-3B2D3D66-6090-425B-AA87-9A1AEBC1D296Q38955561-35FF0213-1949-4401-AF5F-560B73549061Q39109430-D3B8180A-4ED8-4AB5-985C-F7E1F6A40B2CQ39208754-E35CD558-9B5A-4C85-806D-5826A945B356Q40086745-F64F58BB-AE9E-4060-9772-6C164C336FD7Q42010342-26C7D2BA-7248-44DE-8961-129C441678D9Q43960624-D7B6B668-3B04-4A77-A980-F92D59BC8C70Q51846287-ACBF1B16-3643-4A92-B3A9-6E97ECE2F2DA
P2860
Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@en
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@nl
type
label
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@en
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@nl
prefLabel
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@en
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@nl
P2093
P2860
P356
P1433
P1476
Interferon-β sensitivity of tu ...... herapy in mouse glioma models.
@en
P2093
Ari Hinkkanen
Janne Ruotsalainen
Jari Heikkilä
Miika Martikainen
Minna Niittykoski
Tuulia Huhtala
Tytti Aaltonen
P2860
P304
P356
10.1038/MT.2012.53
P577
2012-03-20T00:00:00Z